News

Tiffin, Iowa, USA, and Mysuru, Karnataka, India — July 7, 2025 — ORF Biologics, Inc., a U.S.-based biotechnology firm specializing in recombinant protein expression and assay development, and Vipragen Biosciences Pvt. Ltd., a leading preclinical contract research organization (CRO) in India, are pleased to announce a strategic business partnership aimed at accelerating innovation in drug […]

Join us this Friday, July 18, 2025, for an exciting afternoon at the ORF Biologics Open House! We’re opening our doors and inviting you to take a behind-the-scenes look at how we’re advancing cutting-edge biologics to improve human and animal health. Event Details: What to Expect: No RSVP required — just stop by and say hello!

ORF Biologics is thrilled to be attending Bio 2025 in Boston from June 16-19. We invite you to visit us at Exhibitor Booth 1789, where our team will be showcasing the latest advancements in biologics. This event is a great opportunity to connect with industry leaders and learn more about how ORF Biologics is driving […]

Tiffin, Iowa — [May 12, 2025] – ORF Biologics, Inc., Iowa’s leading provider of cells, growth factors, biotechnology tools, and reagents, proudly announces the immediate availability of standard CHO-K1 and HEK293 cell lines, accompanied by custom-matched growth media designed for optimal performance in both research and production environments. These two cell lines—Chinese Hamster Ovary (CHO-K1) […]

Tiffin, Iowa — [February 27, 2025] – ORF Biologics, a leading biotechnology company based in Tiffin, Iowa, is proud to announce its innovative approach to the design and manufacturing of both standard and custom biologics, including peptides, proteins, and antibodies. Under the leadership of CEO Anant Kamath, a seasoned industry expert with over 35 years […]